This program provides an overview of tardive dyskinesia and Huntington’s disease (HD) chorea, including phenomenology, prevalence, impacts, and risk factors. Faculty will share the clinical data for an FDA-approved treatment option for adults with tardive dyskinesia and HD chorea. In addition, participants will have the opportunity to examine cases of patients with tardive dyskinesia and those with HD chorea by observing videos of the patients before and after treatment. This non-CME educational program is organized by Neurocrine Biosciences.
--- Parkinson and Movement Disorder Alliance (PMD Alliance) has agreed to share information on this non-CME activity. The program was not produced, nor subject to review, by PMD Alliance and is not part of the continuing medical education program offered by PMD Alliance. PMD Alliance does not endorse the specific product or message presented. PMD Alliance will never share your name, e-mail, or other contact information with sponsors without your consent.
